The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients.
about
An in vitro evaluation of standard rotational thromboelastography in monitoring of effects of recombinant factor VIIa on coagulopathy induced by hydroxy ethyl starchRecombinant factor VIIa.Recombinant activated factor VII in patients at high risk of bleeding.Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.A brief historical review of the waterfall/cascade of blood coagulation.Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.An overview of blood-sparing techniques used in spine surgery during the perioperative period.Recombinant factor VIIa in the treatment of non-hemophiliac bleeding.Intraoperative pediatric blood transfusion therapy: a review of common issues. Part II: transfusion therapy, special considerations, and reduction of allogenic blood transfusions.Recombinant factor VIIa as an adjunctive therapy for patients requiring large volume transfusion: a pharmacoeconomic evaluation.Recombinant coagulation factor VIIa--a novel haemostatic agent in scoliosis surgery?Use of recombinant factor VIIa (NovoSeven) in pediatric cardiac surgery.A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery.Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs.Hemostatic strategies for traumatic and surgical bleeding.The interaction of factor VIIa with rehydrated, lyophilized plateletsPoly-N-acetylglucosamine fibers amplify the effectiveness of recombinant factor VIIA on clot formation in hemophilia B canine blood.Recombinant activated factor VII.Successful use of recombinant factor VIIa for severe surgical liver bleeding in a 5 month-old baby.The use of recombinant factor VIIa for bleeding in paediatric practice.Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series.Critical bleeding in vascular surgery: expanding the indication of recombinant activated factor VII.
P2860
Q24797362-B585B0A3-C869-46A0-A826-05773666EDBBQ33363658-49A28018-7364-4FE6-8CF0-5E20B5857843Q33365354-88424252-7AC9-40CB-86ED-D3EF6371D2BCQ33369021-A14D55CE-641C-4037-AF25-E2528EDF29E1Q35564946-8995BECE-7300-49A7-B92D-8DACC26BEA73Q35839531-002EB335-1953-41E6-BB2E-BE78970C94F3Q35916437-1924789E-47C0-419E-8507-94E5912EA49AQ36077574-26373B84-AAEE-46BC-AD8F-7E66AA7EB3ADQ36263592-A4543B97-6766-4707-AE3E-A034BEAF2607Q36263655-EDC98FE5-84C7-4D5A-9AD8-FDC83A3A97F5Q36372563-98FFAAA8-AE58-4B43-ADBE-4E84ACC37DF9Q36375859-369CB7DF-6863-4D56-8056-F4D4DD30B12CQ37095548-BF6B421A-1C04-4906-A496-67510038C4C5Q37691716-944A44A8-8E40-468D-B596-EB7491044C17Q38168784-70398056-CD83-40B2-849C-7D3F4722853AQ41957484-C1389C83-23B2-4293-86D1-17A8E1CC0459Q42139651-33BB9D8E-D6EA-4859-8E90-296F7D649F9DQ45861831-AC2D8D19-C544-4B9B-86E0-F850FA274642Q45872694-F1C29765-AA8C-48B2-A4E0-E6544B99A513Q45882489-A64F3B68-49F2-4855-9B69-217B85C0CB2DQ50664916-592585EA-343C-42AD-8338-3A08493A8E2FQ53252658-34BDA306-C6C5-4403-BA31-3DAF466E82FD
P2860
The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
The use of recombinant factor ...... in non-haemophiliac patients.
@ast
The use of recombinant factor ...... in non-haemophiliac patients.
@en
The use of recombinant factor ...... in non-haemophiliac patients.
@nl
type
label
The use of recombinant factor ...... in non-haemophiliac patients.
@ast
The use of recombinant factor ...... in non-haemophiliac patients.
@en
The use of recombinant factor ...... in non-haemophiliac patients.
@nl
prefLabel
The use of recombinant factor ...... in non-haemophiliac patients.
@ast
The use of recombinant factor ...... in non-haemophiliac patients.
@en
The use of recombinant factor ...... in non-haemophiliac patients.
@nl
P356
P1476
The use of recombinant factor ...... in non-haemophiliac patients.
@en
P2093
Maadh Aldouri
P356
10.1159/000057301
P478
32 Suppl 1
P577
2002-01-01T00:00:00Z